Back to Authors

Zeng, Hu

Mayo Clinic

Mayo Clinic

Citations 1

Histone deacetylase 3 represses cholesterol efflux during CD4+ T-cell activation
Wilfahrt, Drew, Philips, Rachael L, Lama, Jyoti, Kizerwetter, Monika , Shapiro, Michael Jeremy, McCue, Shaylene A, Kennedy, Madeleine M, Rajcula, Matthew J, Zeng, Hu, Philips, Rachael L. , Wilfahrt, Drew N. , Lama, Jyoti , Shapiro, Virginia S , Lama, Jyoti, Kizerwetter, Monika , Shapiro, Michael Jeremy, McCue, Shaylene A, Kennedy, Madeleine M, Rajcula, Matthew J, Zeng, Hu

eLife | November 16, 2021 | Volume: 10 | Issue: No issue available | Pages: No page available

10.7554/elife.70978 Get It

After antigenic activation, quiescent naive CD4 + T cells alter their metabolism to proliferate. This metabolic shift increases production of nucleotides, amino acids, fatty acids, and sterols. Here, we show that histone deacetylase 3 (HDAC3) is critical for activation of murine peripheral CD4 + T cells. HDAC3-deficient CD4 + T cells failed to proliferate and blast after in vitro TCR/CD28 stimulation. Upon T-cell activation, genes involved in cholesterol biosynthesis are upregulated while genes that promote cholesterol efflux are repressed. HDAC3-deficient CD4 + T cells had reduced levels of cellular cholesterol both before and after activation. HDAC3-deficient cells upregulate cholesterol synthesis appropriately after activation, but fail to repress cholesterol efflux; notably, they overexpress cholesterol efflux transporters ABCA1 and ABCG1. Repression of these genes is the primary function for HDAC3 in peripheral CD4 + T cells, as addition of exogenous cholesterol restored proliferative capacity. Collectively, these findings demonstrate HDAC3 is essential during CD4 + T-cell activation to repress cholesterol efflux.